Concepedia

Daniel Ng

DN

Statistics

Publications

10

Citations

731

H-Index

10

Active since

2012

Affiliations

Astellas Pharma (United States)(Current)

Kaiser Permanente

Regenstrief Institute

Medical Decision Modeling (United States)

Indiana University – Purdue University Indianapolis

Daniel Ng is an author at Astellas Pharma (United States) specializing in overactive bladder, overactive bladder management, and pharmacy.

ORCID

Publications per year

2012–2019

10

Publications

10

The HMO Research Network Virtual Data Warehouse: A Public Data Model to Support Collaboration

Tyler Ross, Daniel Ng, Jeffrey S. Brown et al. · eGEMs (Generating Evidence & Methods to improve patient outcomes) · 2014 · 407 citations · Full text

, , +17

Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population

Noll L. Campbell, Anthony J. Perkins, Pamela Bradt et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2016 · 104 citations · Full text

, , +16

Validation of acute myocardial infarction in the Food and Drug Administration's Mini‐Sentinel program

Sarah L. Cutrona, Sengwee Toh, Aarthi Iyer et al. · Pharmacoepidemiology and Drug Safety · 2012 · 81 citations · Full text

, , +14

The Relationship Between Anticholinergic Exposure and Falls, Fractures, and Mortality in Patients with Overactive Bladder

Brandon T. Suehs, Eleanor O. Caplan, Jennifer Hayden et al. · Drugs & Aging · 2019 · 37 citations

, , +9

Mirabegron for the treatment of overactive bladder: cost-effectiveness from US commercial health-plan and Medicare Advantage perspectives

Ronald C. Wielage, Sinem Perk, Noll L. Campbell et al. · Journal of Medical Economics · 2016 · 32 citations

, , +17

1–5 of 10